title: Polymyositis following autologous haematopoietic stem cell transplantation.
authors.affiliation: a Copenhagen Neuromuscular Center, Department of Neurology , University of Copenhagen , Copenhagen , Denmark.
authors.forename: G
authors.initials: G
authors.lastname: Hedermann
authors.affiliation: b Department of Clinical Immunology , University of Copenhagen , Copenhagen , Denmark.
authors.forename: H V
authors.initials: HV
authors.lastname: Marquart
authors.affiliation: a Copenhagen Neuromuscular Center, Department of Neurology , University of Copenhagen , Copenhagen , Denmark.
authors.forename: J
authors.initials: J
authors.lastname: Vissing
mesh_terms: D058846:Antibodies, Monoclonal, Murine-Derived / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000627:therapeutic use; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D003520:Cyclophosphamide / Q000627:therapeutic use; D004317:Doxorubicin / Q000627:therapeutic use; D004576:Electromyography; D005260:Female; D005938:Glucocorticoids / Q000627:therapeutic use; D018380:Hematopoietic Stem Cell Transplantation / Q000009:adverse effects*; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use; D007155:Immunologic Factors / Q000627:therapeutic use; D008224:Lymphoma, Follicular / Q000628:therapy*; D016403:Lymphoma, Large B-Cell, Diffuse / Q000628:therapy*; D060046:Maintenance Chemotherapy; D009364:Neoplasm Recurrence, Local / Q000628:therapy*; D017285:Polymyositis / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology* / Q000473:pathology; D011239:Prednisolone / Q000627:therapeutic use; D011241:Prednisone / Q000627:therapeutic use; D000069283:Rituximab / Q000627:therapeutic use; D012983:Soft Tissue Neoplasms / Q000628:therapy*; D040521:Subcutaneous Tissue; D014182:Transplantation, Autologous; D014750:Vincristine / Q000627:therapeutic use
chemical_list: D058846:Antibodies, Monoclonal, Murine-Derived; D000970:Antineoplastic Agents; D005938:Glucocorticoids; D016756:Immunoglobulins, Intravenous; D007155:Immunologic Factors; C571759:R-CHOP protocol; D000069283:Rituximab; D014750:Vincristine; D004317:Doxorubicin; D003520:Cyclophosphamide; D011239:Prednisolone; D011241:Prednisone